Our Analysis
The New York Times profiled Americans who traveled to Belgium, India, and other countries for hip replacement surgery — not because they wanted an exotic vacation, but because the same procedure with the same implant cost $13,000 abroad versus $100,000+ in the United States.
The patients featured in the article were not uninsured or destitute. Many had insurance but faced deductibles and coinsurance that made the US price prohibitive. A retired teacher on Medicare found that her out-of-pocket cost for a hip replacement at a US hospital exceeded her annual pension. Flying to Belgium, having the surgery, recovering in a hotel, and flying home still cost less.
The implants were identical — the same manufacturer, the same model number, the same titanium-and-ceramic device. The surgeons had comparable training and credentials. The only difference was the price.
Medical tourism is the market's answer to price opacity. When domestic prices are so disconnected from reality that it's cheaper to fly across the ocean for surgery, the pricing system isn't just inefficient — it's broken.
Original source
Read the original article on New York TimesKey Takeaways
Hip replacement costs $100,000+ in the US vs. $13,000 abroad — same implant, same quality
Medical tourism is a rational response to irrational domestic pricing
Even patients with insurance find US costs prohibitive due to deductibles
The pricing problem isn't the technology or the doctors — it's the system
Why It Matters for PricePain
Nobody should have to fly to another country for affordable healthcare. PricePain exists so that the $13,000 hip replacement can be found domestically — because many US providers offer competitive pricing too. They just need a platform to make those prices visible.